Novartis Ag (NVS) Non-Current Debt (2016 - 2025)
Historic Non-Current Debt for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $27.9 billion.
- Novartis Ag's Non-Current Debt rose 3074.51% to $27.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $27.9 billion, marking a year-over-year increase of 3074.51%. This contributed to the annual value of $27.9 billion for FY2025, which is 3074.51% up from last year.
- According to the latest figures from Q4 2025, Novartis Ag's Non-Current Debt is $27.9 billion, which was up 3074.51% from $22.6 billion recorded in Q3 2025.
- Over the past 5 years, Novartis Ag's Non-Current Debt peaked at $27.9 billion during Q4 2025, and registered a low of $17.2 billion during Q1 2024.
- Its 5-year average for Non-Current Debt is $21.7 billion, with a median of $21.9 billion in 2022.
- In the last 5 years, Novartis Ag's Non-Current Debt crashed by 1787.06% in 2023 and then soared by 3144.79% in 2024.
- Quarter analysis of 5 years shows Novartis Ag's Non-Current Debt stood at $22.9 billion in 2021, then fell by 11.61% to $20.2 billion in 2022, then fell by 8.93% to $18.4 billion in 2023, then rose by 15.89% to $21.4 billion in 2024, then skyrocketed by 30.75% to $27.9 billion in 2025.
- Its Non-Current Debt stands at $27.9 billion for Q4 2025, versus $22.6 billion for Q3 2025 and $22.5 billion for Q2 2025.